Stock Information
Aquestive Therapeutics Inc (AQST)
Ticker Symbol: AQST
Exchange: NASDAQ
Sector: Pharmaceuticals
Market Cap: $398.89 mil
Piotroski score: 5
PE Ratio: N/A
EPS (TTM): -0.7771
Revenue (TTM): $0.36 M
Dividend Yield: N/A%
ROE: -21.76417%
Latest News
-
Aquestive Therapeutics Reaffirms Guidance To Resubmit The Anaphylm NDA In Q3 2026; Final FDA Meeting Minutes Expected By Early May 2026
Mon, Mar 30, 2026 7:16 AM
-
Aquestive Therapeutics Completes In-Person Type A Meeting With FDA Regarding Resubmission Of NDA For Anaphylm Sublingual Film For Treatment Of Type 1 Allergic Reactions, Including Anaphylaxis
Mon, Mar 30, 2026 7:15 AM
Key Financials
Financial data not available
